Berry-Kravis · Epilepsia 2001 · uncontrolled observational cohort study · n=46

Carnitine levels and the ketogenic diet.

Cited 79 times in the scientific literature.

Level 4 - case-series / case-control

Uncontrolled prospective and retrospective case series

PubMed 11879348 · doi:10.1046/j.1528-1157.2001.18001.x · record verified 2026-08-30

What was done

Total carnitine levels were measured at baseline, 1, 6, 12, and 24 months in 38 consecutive patients starting the ketogenic diet between May 1997 and March 2000, alongside follow-up measurements in 8 patients started before May 1997. Investigators evaluated relationships between total carnitine, antiepileptic drug (AED) history, lowest blood glucose, time to achieve ketosis, and clinical diet complications.

What was found

Total carnitine at diet initiation correlated negatively with the number of concurrent AEDs, but not with the number of past AEDs, lowest blood glucose, or time to ketosis. Total carnitine declined during the first months of diet treatment and then stabilized or increased slightly with long-term therapy. Overall, 19% of patients received carnitine supplementation for low total carnitine, and no patients exhibited clinical signs of carnitine deficiency. Numerical values, standard deviations, and correlation coefficients were not reported in the abstract.

Why it matters

This study suggests that while carnitine levels drop modestly early during ketogenic diet therapy, symptomatic deficiency is rare and routine carnitine supplementation is generally not required.

Limits

Small sample size (38 prospective and 8 retrospective patients) without a control group. The abstract omits exact numerical values, effect sizes, and p-values for all measured outcomes.

Cited by